MINNEAPOLIS, Jan. 6, 2020 /PRNewswire/ — Vireo Health International, Inc. („Vireo” or the „Company”) (CNSX: VREO, OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced the launch of LiteBud, a patent-pending line of consistently formulated, lower-Tetrahydrocannabinol (THC) cannabis products that are designed to meet the needs of cannabis consumers seeking a more consistent, controlled and mild experience.
the average THC potency was approximately 4%, increasing to 8.9% in 2008, and then again to 17.1% in 2017. Today, most flower available in medical and adult-use markets is cultivated to maximize potency and sophisticated techniques often yield THC levels that exceed 25%, in contrast to LiteBud products which contain lower THC levels, ranging from 4 to 10%.” data-reactid=”20″>Research studies conducted at the University of Mississippi found that the THC potency of cannabis plant material has more than quadrupled over the past generation. In 1995, the average THC potency was approximately 4%, increasing to 8.9% in 2008, and then again to 17.1% in 2017. Today, most flower available in medical and adult-use markets is cultivated to maximize potency and sophisticated techniques often yield THC levels that exceed 25%, in contrast to LiteBud products which contain lower THC levels, ranging from 4 to 10%.
Kyle Kingsley, M.D. „LiteBud offers patients a lower-THC product line with carefully controlled cannabinoid levels to help prevent the unpleasant side effects many experience with high-THC products. In a sense, this is your father’s cannabis since its cannabinoid levels are more reminiscent of the type of flower that was widely used a generation or two ago.”
Maryland’s growing medical cannabis market.
Harris Rabin, Chief Marketing Officer of Vireo Health. „As the U.S. cannabis market matures and serves a broader segment of the adult population, we believe that there will be a significant consumer demand for low-THC products.”
www.litebud.com.” data-reactid=”24″>LiteBud pre-rolls are currently available at dispensaries throughout the State of Maryland. Later this year, Vireo plans to offer LiteBud products in other key markets in which it operates. Learn more about the brand by visiting www.litebud.com.
www.vireohealth.com.” data-reactid=”26″>Vireo Health International, Inc.’s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo’s physician-led team of more than 400 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently is licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, New Mexico, New York, Nevada, Ohio, Pennsylvania, Puerto Rico, and Rhode Island. For more information about the Company, please visit www.vireohealth.com.
(267) 221-4800″ data-reactid=”28″>Media Inquiries
Vice President, Corporate Communications